| Structure and functional binding epitope of V-domain Ig suppressor of T cell activation N Mehta, S Maddineni, II Mathews, RAP Sperberg, PS Huang, ... Cell reports 28 (10), 2509-2516. e5, 2019 | 77 | 2019 |
| Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells S Maddineni, JL Silberstein, JB Sunwoo Journal for Immunotherapy of Cancer 10 (5), 2022 | 42 | 2022 |
| An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA N Mehta, S Maddineni, RL Kelly, RB Lee, SA Hunter, JL Silberstein, ... Scientific reports 10 (1), 15171, 2020 | 42 | 2020 |
| Updates in eustachian tube dysfunction S Maddineni, I Ahmad Otolaryngologic Clinics of North America 55 (6), 1151-1164, 2022 | 10 | 2022 |
| Oral cavity cancer in young, non-smoking, and non-drinking patients: A contemporary review Q Tran, S Maddineni, EH Arnaud, V Divi, U Megwalu, MC Topf, ... Critical Reviews in Oncology/Hematology, 104112, 2023 | 7 | 2023 |
| DynaRing: a patient-specific mitral annuloplasty ring with selective stiffness segments S Frishman, A Kight, I Pirozzi, S Maddineni, AM Imbrie-Moore, ... Journal of Medical Devices 16 (3), 031009, 2022 | 5 | 2022 |
| Vista-binding antibodies and uses thereof RL KELLY, N METHA, JR Cochran, S MADDINENI | 1 | 2020 |
| ASO Visual Abstract: Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma S Maddineni, MP Dizon, V Muralidharan, LA Young, JB Sunwoo, FM Baik, ... Annals of surgical oncology 31 (4), 2751-2752, 2024 | | 2024 |
| Validation of the Melanoma Institute of Australia’s Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma S Maddineni, MP Dizon, V Muralidharan, LA Young, JB Sunwoo, FM Baik, ... Annals of Surgical Oncology 31 (4), 2737-2746, 2024 | | 2024 |
| 995 Modulation of the inflammatory response within the tumor microenvironment by intraepithelial ILC1-like natural killer cells S Maddineni, IA Mohammad, K Sharma, JH Shin, JB Sunwoo Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Abstract PO-091: Leveraging tissue-resident CD103+ NK cells for adoptive cell therapy in head and neck cancer NB Horowitz, JH Shin, S Maddineni, IA Mohammad, AX Liu, JB Sunwoo Clinical Cancer Research 29 (18_Supplement), PO-091-PO-091, 2023 | | 2023 |
| Toll-like Receptor Agonists Are Unlikely to Provide Benefits in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis S Maddineni, M Chen, F Baik, V Divi, JB Sunwoo, A Finegersh Cancers 15 (17), 4386, 2023 | | 2023 |
| The need for need-finding in medical education S Maddineni, W Kumar Nature Biotechnology 41 (7), 1028-1030, 2023 | | 2023 |
| 1180 Single institution validation of a sentinel lymph node biopsy risk prediction tool for cutaneous melanoma V Muralidharan, S Maddineni, L Young, J Sunwoo, FM Baik, S Swetter Journal of Investigative Dermatology 143 (5), S203, 2023 | | 2023 |
| Abstract PO-048: VISTA immune-checkpoint blunts radiotherapy induced anti-tumor immune response DK Nambiar, N Mehta, S Maddineni, H Cao, V Viswanathan, ... Clinical Cancer Research 27 (8_Supplement), PO-048-PO-048, 2021 | | 2021 |
